UFPT
UFP Technologies, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$287.48
+0.34%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 631.6M | 602.8M | 504.4M | 400.1M | 353.8M |
| Cost of Revenue | 451.6M | 432.4M | 357.7M | 287.8M | 263.5M |
| Gross Profit | 180.0M | 170.4M | 146.7M | 112.2M | 90.3M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 83.8M | 77.4M | 62.2M | 50.9M | 45.8M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (130.0K) | 633.0K | 3.6M | 3.7M | (10.9M) |
| Total Operating Expenses | 83.7M | 78.1M | 65.8M | 54.6M | 34.9M |
| Cost and Expenses | 535.3M | 510.5M | 423.5M | 342.4M | 298.4M |
| Operating Income (EBIT) | 96.3M | 92.3M | 80.9M | 57.7M | 55.4M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 7.8M | 9.8M | 8.1M | 3.6M | 2.8M |
| Net Interest Income | (7.8M) | (9.8M) | (8.1M) | (3.6M) | (2.8M) |
| Other Non-Op Income/Expense | (7.7M) | (9.8M) | (7.9M) | (3.8M) | (2.7M) |
| Non-Operating Income (excl Interest) | (91.0K) | 21.0K | (189.0K) | 117.0K | (81.0K) |
| EBT (Pre-Tax Income) | 88.6M | 82.5M | 73.0M | 53.9M | 52.7M |
| Income Tax Expense | 16.3M | 14.2M | 14.0M | 9.0M | 10.9M |
| Bottom Line | |||||
| Net Income | 72.3M | 68.3M | 59.0M | 44.9M | 41.8M |
| Earnings from Cont. Ops | 72.3M | 68.3M | 59.0M | 44.9M | 41.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 72.3M | 68.3M | 59.0M | 44.9M | 41.8M |
| Per Share | |||||
| Basic EPS | $9.36 | $8.87 | $7.69 | $5.89 | $5.52 |
| Diluted EPS | $9.27 | $8.77 | $7.58 | $5.83 | $5.45 |
| Revenue Per Share | $81.70 | $78.23 | $65.78 | $52.48 | $46.77 |
| Shares | |||||
| Basic Shares Outstanding | 7.7M | 7.7M | 7.7M | 7.6M | 7.6M |
| Diluted Shares Outstanding | 7.8M | 7.8M | 7.8M | 7.7M | 7.7M |
| Profitability Metrics | |||||
| EBITDA | 115.4M | 115.7M | 95.8M | 69.0M | 67.4M |
| D&A | 19.0M | 23.4M | 14.7M | 11.4M | 11.9M |
| EBIT | 96.4M | 92.3M | 81.1M | 57.5M | 55.5M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026